| Literature DB >> 35944932 |
Sidse Bregendahl1, Peter Bondeven2, Therese Koops Grønborg3, Gina Brown4, Søren Laurberg5, Bodil Ginnerup Pedersen6.
Abstract
BACKGROUND: MRI interpretation and accurate radiological staging are crucial to the important treatment decisions and a consequent successful patient outcome in rectal cancer. AIMS: To investigate the effect of intensive training on rectal cancer MRI staging performance of radiologists and the impact of different course elements on learning outcomes.Entities:
Keywords: Continuing education, continuing professional development; Health professions education; Healthcare quality improvement; Quality improvement
Mesh:
Year: 2022 PMID: 35944932 PMCID: PMC9367186 DOI: 10.1136/bmjoq-2021-001716
Source DB: PubMed Journal: BMJ Open Qual ISSN: 2399-6641
Figure 1Flow chart of training programme.
Characteristics of the participating 17 radiology specialists and one radiology registrar
| Characteristics | No. of participants | |
| Median age, years (range) | 47 | (37–64) |
| Years of experience in radiology, no. (%) | ||
| ≤5 years | 1 | (6) |
| 6–10 years | 8 | (44) |
| 11–20 years | 4 | (22) |
| 21–30 years | 5 | (28) |
| Years of experience reading rectal MRI, no. (%) | ||
| 0 years | 5 | (28) |
| 1–2 years | 5 | (28) |
| 3–5 years | 6 | (23) |
| 6–10 years | 2 | (11) |
| Regular attendance in rectal cancer MDT meetings, no. (%) | ||
| Yes | 12 | (67) |
| No | 6 | (33) |
| Plans of running rectal cancer MDT meetings, no. (%) | ||
| Yes | 14 | (78) |
| No | 0 | (0) |
| Uncertain | 4 | (22) |
MDT, multidisciplinary team.
Radiologists’ performance on key staging parameters and prognostic factors in rectal MRI
| Overall (n=18) | Adjusted OR (95% CI) | ||||
| Baseline | End of course | ||||
| All cases (n=30) | |||||
| Tumour category* | 69% | (360/524) | 76% | (406/533) | 1.66 (1.21 to 2.27) |
| Tumour stage, early vs advanced† | 90% | (467/521) | 92% | (487/531) | 1.40 (0.87 to 2.23) |
| Tumour height category | 79% | (415/528) | 82% | (440/534) | 1.43 (0.998 to 2.04) |
| Tumour location | 1.52 | ±0.52 | 1.14 | ±0.43 | 0.38 (0.23 to 0.54) |
| Lymph node status | 86% | (452/524) | 85% | (453/531) | 0.90 (0.62 to 1.30) |
| EMVI status | 79% | (380/483) | 83% | (431/518) | 1.51 (1.04 to 2.19) |
| Cases with T3 or T4 tumours (n=19) | |||||
| Tumour-free MRF, 5 mm level | 68% | (91/134) | 81% | (109/134) | 3.68 (1.69 to 8.02) |
| Tumour-free MRF, 1 mm level | 79% | (120/152) | 88% | (133/151) | 2.88 (1.30 to 6.38) |
Data are percentages (number/total) and OR for agreeing with the reference standard (95% CI), except for tumour location, which is the difference between the clock face centre of the tumour derived from the participants’ registrations compared with the ones derived from the reference standard, expressed as means (hours), SD and difference of means from baseline to end of course (95% CI).
*Tumour category: T1, T2, T3, T4.
†Early tumours: T1, T2, T3a–b; advanced tumours: T3c–d, T4a–b.
EMVI, extramural vascular invasion; MRF, mesorectal fascia.
Radiologists’ performance on key staging parameters and prognostic factors in rectal MRI, stratified by performance status
| Low performance group (n=9) | Adjusted OR (95% CI) | High performance group (n=9) | Adjusted OR (95% CI) | |||||||
| Baseline | End of course | Baseline | End of course | |||||||
| All cases (n=30) | ||||||||||
| Tumour category* | 62% | (158/255) | 77% | (202/264) | 2.60 (1.68 to 4.02) | 75% | (202/269) | 76% | (204/269) | 1.05 (0.67 to 1.63) |
| Tumour stage, early vs advanced† | 86% | (220/255) | 89% | (235/263) | 1.50 (0.82 to 2.73) | 93% | (247/266) | 94% | (252/268) | 1.27 (0.61 to 2.63) |
| Tumour height category | 74% | (192/260) | 81% | (214/265) | 1.75 (1.08 to 2.86) | 83% | (223/268) | 84% | (226/269) | 1.10 (0.63 to 1.93) |
| Tumour location | 1.76 | ±0.30 | 1.33 | ±0.39 | 0.42 (0.19 to 0.64) | 1.29 | ±0.60 | 0.94 | ±0.39 | 0.35 (0.13 to 0.57) |
| Lymph node status | 86% | (221/256) | 89% | (235/263) | 1.40 (0.80 to 2.43) | 86% | (231/268) | 81% | (218/268) | 0.63 (0.37 to 1.07) |
| EMVI status | 79% | (182/229) | 79% | (199/251) | 0.98 (0.58 to 1.65) | 78% | (198/254) | 87% | (232/267) | 2.36 (1.38 to 4.04) |
| Cases with T3 or T4 tumours (n=19) | ||||||||||
| Tumour-free MRF, 5 mm level | 49% | (33/68) | 76% | (50/66) | 10.80 (3.75 to 31.17) | 88% | (58/66) | 87% | (59/68) | 0.83 (0.23 to 3.00) |
| Tumour-free MRF, 1 mm level | 68% | (52/77) | 87% | (65/75) | 6.89 (2.56 to 18.52) | 91% | (68/75) | 89% | (68/76) | 0.84 (0.24 to 2.93) |
Data are percentages (number/total) and OR for agreeing with the reference standard (95% CI), except for tumour location, which is the difference between the clock face centre of the tumour derived from the participants’ registrations compared with the ones derived from the reference standard, expressed as means (hours), SD and difference of means from baseline to end of course (95% CI).
*Tumour category: T1, T2, T3, T4.
†Early tumours: T1, T2, T3a–b; advanced tumours: T3c–d, T4a–b.
EMVI, extramural vascular invasion; MRF, mesorectal fascia.
Radiologists’ self-evaluated confidence scores and learning outcome scores, overall and stratified by performance status
| Overall (n=18) | P value | Low performance group (n=9) | P value | High performance group (n=9) | P value | ||||||||||
| Baseline | End of course | Baseline | End of course | Baseline | End of course | ||||||||||
| Confidence scores | |||||||||||||||
| More confident to actively participate in the MDT meeting | 3.3 | (2.8 to 3.8) | 4.3 | (3.9 to 4.7) | <0.001 | 3.5 | (2.8 to 4.2) | 4.3 | (3.8 to 4.9) | 0.04 | 3.1 | (2.5 to 3.7) | 4.2 | (3.6 to 4.8) | <0.001 |
| More confident to enter into dialogue with other MDT members regarding the MRI assessment | 3.4 | (2.9 to 3.9) | 4.3 | (3.9 to 4.8) | 0.001 | 4.0 | (3.3 to 4.8) | 4.3 | (3.7 to 4.9) | 0.47 | 3.0 | (2.4 to 3.6) | 4.3 | (3,7 to 4.9) | <0.001 |
| Acquired improved routines in rectal MRI assessment | 3.8 | (3.4 to 4.2) | 4.4 | (4.0 to 4.8) | 0.03 | 3.8 | (3.1 to 4.5) | 4.6 | (4.0 to 5.1) | 0.08 | 3.8 | (3.2 to 4.3) | 4.2 | (3.7 to 4.8) | 0.18 |
| Learning outcome scores | |||||||||||||||
| Case readings | 3.8 | (3.4 to 4.2) | 4.3 | (4.0 to 4.7) | 0.04 | 3.7 | (3.0 to 4.3) | 4.3 | (3.8 to 4.8) | 0.08 | 3.9 | (3.4 to 4.4) | 4.3 | (3.8 to 4.8) | 0.14 |
Data are mean scores at baseline and end of course (95% CI).
MDT, multidisciplinary team.